Market Value231,803,000
Total Holdings79
File Date2019-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PHAS / PhaseBio Pharmaceuticals Inc
45784PAG6 / Insulet Corp Bond
DRNA / Dicerna Pharmaceuticals Inc
VKTX / Viking Therapeutics, Inc.
STRO / Sutro Biopharma, Inc.
INGN / Inogen, Inc.
URGN / UroGen Pharma Ltd.
IBB / iShares Trust - iShares Biotechnology ETF
XENE / Xenon Pharmaceuticals Inc.
BPMC / Blueprint Medicines Corporation
LRMR / Larimar Therapeutics, Inc.
SLGL / Sol-Gel Technologies Ltd.
US750469AA69 / Radius Health, Inc. Bond
US55027E1029 / Luminex Corporation
AGTC / Applied Genetic Technologies Corp
ABUS / Arbutus Biopharma Corporation
RDUS / Radius Recycling, Inc.
ARDX / Ardelyx, Inc.
SPRO / Spero Therapeutics, Inc.
JNJ / Johnson & Johnson
NERV / Minerva Neurosciences, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
KALV / KalVista Pharmaceuticals, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
APTX / Aptinyx Inc.
/ Immunomedics, Inc.
VBIV / VBI Vaccines Inc.
OBSV / ObsEva SA.
IL0011177958 / Intec Pharma Ltd
FOMX / Foamix Pharmaceuticals Ltd.
CNCE / Concert Pharmaceuticals Inc
NXTM / NxStage Medical, Inc.
ORMP / Oramed Pharmaceuticals Inc.
US252131AF44 / Dexcom Inc Bond
VLRX / Valeritas, Inc.
LOXO / Loxo Oncology, Inc.
US64052L1061 / Neos Therapeutics, Inc.
INCY / Incyte Corporation
US00448Q2012 / Achillion Pharmaceuticals, Inc.
DERM / Journey Medical Corporation
ZGNX / Zogenix Inc
ALRN / Rein Therapeutics Inc.
ADXS / Ayala Pharmaceuticals, Inc.
ARQL / ArQule, Inc.
YMTX / Yumanity Therapeutics Inc
NTUS / Natus Medical Inc
KDMN / Kadmon Holdings Inc
US0906721065 / BioTelemetry, Inc.
LPTX / Leap Therapeutics, Inc.
PRQR / ProQR Therapeutics N.V.
TBIO / Telesis Bio, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
MGNX / MacroGenics, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
ARNA / Arena Pharmaceuticals Inc
AERI / Aerie Pharmaceuticals Inc
GNCA / Genocea Biosciences Inc
SVRA / Savara Inc.
WVE / Wave Life Sciences Ltd.
ASMB / Assembly Biosciences, Inc.
STXS / Stereotaxis, Inc.
VYNE / VYNE Therapeutics Inc.
US014339AA35 / Alder Biopharmaceuticals Inc Bond
AKBA / Akebia Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
ALDX / Aldeyra Therapeutics, Inc.
CSII / Cardiovascular Systems Inc.
CARA / Cara Therapeutics, Inc.
BLUE / bluebird bio, Inc.
DXCM / DexCom, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
CBAY / CymaBay Therapeutics, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
SAGE / Sage Therapeutics, Inc.
CDTX / Cidara Therapeutics, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
ALEC / Alector, Inc.
NVRO / Nevro Corp.
CYTK / Cytokinetics, Incorporated
MRSN / Mersana Therapeutics, Inc.
MASI / Masimo Corporation
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
BHVN / Biohaven Ltd.
ATRC / AtriCure, Inc.
KURA / Kura Oncology, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
LCTX / Lineage Cell Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.